Open · Transparency Ledger

Show your work.

Every article on this site, every source we cite, every language we publish in. Counted at deploy time, not hand-curated. If a number changes, the page changes with it.

Status
live · static
Commit
local
Built
15 May 2026 13:18:18 UTC
Runtime
Astro 5.18.1 · zero JS bundle
01 · The contract

Three numbers. They’re the whole brand promise.

Studies cited
205

Unique peer-reviewed studies and references across the live library.

Sources whitelisted
104

Tier-A and Tier-B publishers. Anything else is off-limits.

Unsourced claims
0

Every numeric statement carries a footnote. Zero exceptions.

Numbers regenerated on every deploy Counted from src/content tree Last build: 15 May 2026 13:18:18 UTC
02 · What we publish

Four languages. Lots of information.

Articles
101

Live in production today, across all languages.

Words published
220,000+

Source-checked, edited, and footnoted by hand.

In-line citations
915

Footnote references resolving to 205 unique studies.

Languages
4

EN, DE, ES, FR. Every post written natively, not machine-translated.

Articles by locale

Updated May 15, 2026
ENEnglish
29
29%
DEDeutsch
24
24%
ESEspañol
24
24%
FRFrançais
24
24%
No surveillance

We use Umami for traffic counts. No cookies, no fingerprinting, no tracking pixels. Your email lives in one place and you can delete it whenever you want.

Read the disclosure →
03 · Where facts come from

The editorial whitelist. Tier A and Tier B only.

Whitelisted sources
104

The editorial allow-list. Nothing outside it reaches a page.

Countries covered
12

EU member states, UK, and selected international bodies.

Regulatory bodies
5

EFSA, EMA, WHO, Cochrane, plus national equivalents.

Peer-reviewed journals
18

Including Gut, AJCN, Lancet Gastro, NEJM.

Regulatory and scientific bodies we cite

13 · live
EFSA EUEMA EUWHO Intl.Cochrane Intl.DGE DEANSES FRBNF UKFEN ESNICE UKBfR DEINSERM FRCDC USNIH US

Watch the numbers grow.

Get the working prototype data and the launch date. No product pitches until there’s a product to pitch.